Evaheart, Inc

LEADING LVAD COMPANY IN THE STATE OF TEXAS Evaheart, Inc. (EVI) is a medical device company based in the Texas Medical Center of Houston. EVI was established to gain regulatory approval and commercialize the EVAHEART2 Left Ventricular Assist System in the North American market and start distribution in Europe. Under an FDA-approved IDE, a Multi-Center Prospective Randomized Clinical Trial (COMPETENCE TRIAL) of the EVAHEART2 LVAS is currently ongoing in US. OUR MISSION To return severe heart failure patients to their home with high quality of life. WHAT WEVE ACHIEVED - Over 9-year durability testing with no mechanical failure. - Regulatory clearance granted (by PMDA) and now clinically used in Japan - Total 183 EVAHEART LVAS have been implanted to-date (July-2018). - IDE (Investigational Device Exemption) approved by the FDA. - IDE clinical trial (BTT trial) in North America is underway. - New miniaturized pump and inflow cannula are implemented. RESPECT PULSATILITY